Medtronic PLC (2M6) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Medtronic PLC (2M6) has a cash flow conversion efficiency ratio of 0.056x as of January 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€2.75 Billion ≈ $3.21 Billion USD) by net assets (€49.24 Billion ≈ $57.57 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Medtronic PLC - Cash Flow Conversion Efficiency Trend (1990–2025)
This chart illustrates how Medtronic PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Medtronic PLC (2M6) financial obligations for a breakdown of total debt and financial obligations.
Medtronic PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medtronic PLC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Canadian Imperial Bank Of Commerce
TO:CM
|
-0.067x |
|
Medtronic PLC
NYSE:MDT
|
0.019x |
|
BNP Paribas SA
PA:BNP
|
0.004x |
|
Trane Technologies plc
NYSE:TT
|
0.136x |
|
Constellation Energy Corp
NASDAQ:CEG
|
0.054x |
|
UBS Group AG
SW:UBSG
|
-0.043x |
|
GSK PLC SP. ADR/2 NEW
F:GS70
|
N/A |
|
CVS Health Corp
NYSE:CVS
|
0.045x |
Annual Cash Flow Conversion Efficiency for Medtronic PLC (1990–2025)
The table below shows the annual cash flow conversion efficiency of Medtronic PLC from 1990 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Medtronic PLC.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-04-30 | €48.26 Billion ≈ $56.42 Billion |
€7.04 Billion ≈ $8.24 Billion |
0.146x | +8.44% |
| 2024-04-30 | €50.42 Billion ≈ $58.95 Billion |
€6.79 Billion ≈ $7.93 Billion |
0.135x | +15.16% |
| 2023-04-30 | €51.66 Billion ≈ $60.40 Billion |
€6.04 Billion ≈ $7.06 Billion |
0.117x | -16.11% |
| 2022-04-30 | €52.72 Billion ≈ $61.64 Billion |
€7.35 Billion ≈ $8.59 Billion |
0.139x | +15.22% |
| 2021-04-30 | €51.60 Billion ≈ $60.33 Billion |
€6.24 Billion ≈ $7.30 Billion |
0.121x | -14.96% |
| 2020-04-30 | €50.87 Billion ≈ $59.47 Billion |
€7.23 Billion ≈ $8.46 Billion |
0.142x | +1.90% |
| 2019-04-30 | €50.21 Billion ≈ $58.70 Billion |
€7.01 Billion ≈ $8.19 Billion |
0.140x | +51.41% |
| 2018-04-30 | €50.82 Billion ≈ $59.42 Billion |
€4.68 Billion ≈ $5.48 Billion |
0.092x | -32.46% |
| 2017-04-30 | €50.42 Billion ≈ $58.94 Billion |
€6.88 Billion ≈ $8.04 Billion |
0.136x | +35.54% |
| 2016-04-30 | €51.83 Billion ≈ $60.59 Billion |
€5.22 Billion ≈ $6.10 Billion |
0.101x | +9.33% |
| 2015-04-30 | €53.23 Billion ≈ $62.23 Billion |
€4.90 Billion ≈ $5.73 Billion |
0.092x | -63.89% |
| 2014-04-30 | €19.44 Billion ≈ $22.73 Billion |
€4.96 Billion ≈ $5.80 Billion |
0.255x | -2.48% |
| 2013-04-30 | €18.67 Billion ≈ $21.83 Billion |
€4.88 Billion ≈ $5.71 Billion |
0.262x | +2.16% |
| 2012-04-30 | €17.11 Billion ≈ $20.01 Billion |
€4.38 Billion ≈ $5.12 Billion |
0.256x | +9.27% |
| 2011-04-30 | €15.97 Billion ≈ $18.67 Billion |
€3.74 Billion ≈ $4.37 Billion |
0.234x | -17.03% |
| 2010-04-30 | €14.63 Billion ≈ $17.10 Billion |
€4.13 Billion ≈ $4.83 Billion |
0.282x | -6.42% |
| 2009-04-30 | €12.85 Billion ≈ $15.02 Billion |
€3.88 Billion ≈ $4.53 Billion |
0.302x | -0.22% |
| 2008-04-30 | €11.54 Billion ≈ $13.49 Billion |
€3.49 Billion ≈ $4.08 Billion |
0.302x | +11.44% |
| 2007-04-30 | €10.98 Billion ≈ $12.83 Billion |
€2.98 Billion ≈ $3.48 Billion |
0.271x | +15.35% |
| 2006-04-30 | €9.38 Billion ≈ $10.97 Billion |
€2.21 Billion ≈ $2.58 Billion |
0.235x | -12.80% |
| 2005-04-30 | €10.45 Billion ≈ $12.22 Billion |
€2.82 Billion ≈ $3.30 Billion |
0.270x | -13.94% |
| 2004-04-30 | €9.08 Billion ≈ $10.61 Billion |
€2.85 Billion ≈ $3.33 Billion |
0.314x | +19.28% |
| 2003-04-30 | €7.91 Billion ≈ $9.24 Billion |
€2.08 Billion ≈ $2.43 Billion |
0.263x | +6.30% |
| 2002-04-30 | €6.43 Billion ≈ $7.52 Billion |
€1.59 Billion ≈ $1.86 Billion |
0.247x | -25.62% |
| 2001-04-30 | €5.51 Billion ≈ $6.44 Billion |
€1.83 Billion ≈ $2.14 Billion |
0.332x | +43.29% |
| 2000-04-30 | €4.49 Billion ≈ $5.25 Billion |
€1.04 Billion ≈ $1.22 Billion |
0.232x | +86.22% |
| 1999-04-30 | €3.65 Billion ≈ $4.27 Billion |
€455.30 Million ≈ $532.29 Million |
0.125x | -56.84% |
| 1998-04-30 | €2.04 Billion ≈ $2.39 Billion |
€590.10 Million ≈ $689.89 Million |
0.289x | +8.73% |
| 1997-04-30 | €1.75 Billion ≈ $2.04 Billion |
€463.60 Million ≈ $542.00 Million |
0.265x | -5.09% |
| 1996-04-30 | €1.79 Billion ≈ $2.09 Billion |
€500.50 Million ≈ $585.14 Million |
0.280x | -3.56% |
| 1995-04-30 | €1.33 Billion ≈ $1.56 Billion |
€387.20 Million ≈ $452.68 Million |
0.290x | -14.39% |
| 1994-04-30 | €1.05 Billion ≈ $1.23 Billion |
€356.90 Million ≈ $417.25 Million |
0.339x | -2.20% |
| 1993-04-30 | €841.50 Million ≈ $983.80 Million |
€291.50 Million ≈ $340.79 Million |
0.346x | +82.24% |
| 1992-04-30 | €796.50 Million ≈ $931.19 Million |
€151.40 Million ≈ $177.00 Million |
0.190x | +2.58% |
| 1991-04-30 | €683.20 Million ≈ $798.73 Million |
€126.60 Million ≈ $148.01 Million |
0.185x | -6.13% |
| 1990-04-30 | €541.00 Million ≈ $632.49 Million |
€106.80 Million ≈ $124.86 Million |
0.197x | -- |
About Medtronic PLC
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor sy… Read more